Literature DB >> 10334796

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients.

J Blacher1, R Asmar, S Djane, G M London, M E Safar.   

Abstract

Large artery damage is a major contributory factor to cardiovascular morbidity and mortality of patients with hypertension. Pulse wave velocity (PWV), a classic evaluation of arterial distensibility, has never been ascertained as a cardiovascular risk marker. To determine the factors influencing aortic PWV and the potential predictor role of this measurement, we studied a cohort of 710 patients with essential hypertension. Atherosclerosis alterations (AA) were defined on the basis of clinical events. Calculation of cardiovascular risks, by use of Framingham equations, was performed in subjects without AA. PWV was higher in the presence of AA (14.9+/-4.0 versus 12.4+/-2.6 m/s, P<0.0001), even after adjustments on confounding factors and was the first determinant (P<0.0001) of the extent of atherosclerosis assessed as the sum of the atherosclerotic sites. In patients without AA, all cardiovascular risks increased constantly with PWV. Furthermore, at a given age, aortic PWV was the best predictor of cardiovascular mortality. The odds ratio of being in a high cardiovascular mortality risk group (>5% for 10 years) for patients in the upper quartile of PWV was 7.1 (95% confidence intervals 4.5 to 11.3). The presence of a PWV >13 m/s, taken alone, appeared as a strong predictor of cardiovascular mortality with high performance values. This study shows that aortic PWV is strongly associated with the presence and extent of atherosclerosis and constitutes a forceful marker and predictor of cardiovascular risk in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334796     DOI: 10.1161/01.hyp.33.5.1111

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  288 in total

1.  Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man.

Authors:  I B Wilkinson; H MacCallum; P C Hupperetz; C J van Thoor ; J R Cockcroft; D J Webb
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

2.  Continuous estimation of systolic blood pressure using the pulse arrival time and intermittent calibration.

Authors:  W Chen; T Kobayashi; S Ichikawa; Y Takeuchi; T Togawa
Journal:  Med Biol Eng Comput       Date:  2000-09       Impact factor: 2.602

3.  Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo.

Authors:  Ian B Wilkinson; Helen MacCallum; John R Cockcroft; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

Review 4.  Diastolic pressure, systolic pressure, or pulse pressure?

Authors:  C Vlachopoulos; M O'Rourke
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 5.  The cardiovascular system.

Authors:  A Moore; A A Mangoni; D Lyons; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

6.  Mechanical properties of normal and diseased cerebrovascular system.

Authors:  Ali P Ebrahimi
Journal:  J Vasc Interv Neurol       Date:  2009-04

Review 7.  Arterial aging--hemodynamic changes and therapeutic options.

Authors:  Michel E Safar
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

8.  Measuring pulse wave velocity using ECG and photoplethysmography.

Authors:  An-Bang Liu; Po-Chun Hsu; Zong-Li Chen; Hsien-Tsai Wu
Journal:  J Med Syst       Date:  2010-04-06       Impact factor: 4.460

9.  An automatic method for arterial pulse waveform recognition using KNN and SVM classifiers.

Authors:  Tânia Pereira; Joana S Paiva; Carlos Correia; João Cardoso
Journal:  Med Biol Eng Comput       Date:  2015-09-24       Impact factor: 2.602

10.  Arterial distensibility in children and teenagers: normal evolution and the effect of childhood vasculitis.

Authors:  Y F Cheung; P A Brogan; C B Pilla; M J Dillon; A N Redington
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.